Luciferase Reporter Assay Kit |
55R-1540 |
Fitzgerald |
200 assays |
EUR 180 |
|
Description: Assay Kit for detection of Luciferase Reporter in the research laboratory |
Human IgG antibody Laboratories manufactures the dual luciferase reporter assay system reagents distributed by Genprice. The Dual Luciferase Reporter Assay System reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Dual products are available in stock. Specificity: Dual Category: Luciferase Group: Reporter Assay
Dual Luciferase Reporter Assay Kit |
Vazyme |
100 rxns |
EUR 93.71 |
Single-Luciferase Reporter Assay Kit |
Abbexa |
100 µl |
EUR 650 |
Single-Luciferase Reporter Assay Kit |
Abbexa |
1 ml |
Ask for price |
Single-Luciferase Reporter Assay Kit |
Abbexa |
200 µl |
EUR 762.5 |
Double-Luciferase Reporter Assay Kit |
Abbexa |
100 µl |
EUR 687.5 |
Double-Luciferase Reporter Assay Kit |
Abbexa |
1 ml |
Ask for price |
Double-Luciferase Reporter Assay Kit |
Abbexa |
200 µl |
EUR 900 |
Reporter Assay information
Amplite® Gaussia Luciferase Reporter Gene Assay Kit *Bright Glow* |
12530-1plate |
AAT Bioquest |
1 plate |
EUR 222 |
|
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
Amplite® Gaussia Luciferase Reporter Gene Assay Kit *Bright Glow* |
12531-10Plates |
AAT Bioquest |
10 Plates |
EUR 846 |
|
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
Amplite® Gaussia Luciferase Reporter Gene Assay Kit *Bright Glow* |
12532-100plates |
AAT Bioquest |
100 plates |
EUR 4447 |
|
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
Amplite® Renilla Luciferase Reporter Gene Assay Kit *Bright Glow* |
12535-1plate |
AAT Bioquest |
1 plate |
EUR 222 |
|
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
Amplite® Renilla Luciferase Reporter Gene Assay Kit *Bright Glow* |
12536-10plates |
AAT Bioquest |
10 plates |
EUR 1070 |
|
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
Amplite® Renilla Luciferase Reporter Gene Assay Kit *Bright Glow* |
12537-100plates |
AAT Bioquest |
100 plates |
EUR 4447 |
|
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
Amplite® Luciferase Reporter Gene Assay Kit *Maximized Luminescence* |
12519 |
AAT Bioquest |
10 plates |
EUR 455 |
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
Amplite® Renilla Luciferase Reporter Gene Assay Kit *Maximized Luminescence* |
12536 |
AAT Bioquest |
10 plates |
EUR 1092 |
Description: Common reporter genes include beta-galactosidase, beta-glucuronidase and luciferase. |
SRE Luciferase Reporter Lentivirus |
78627 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The SRE (Serum Response Element) Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the Serum Response Element located upstream of the minimal TATA promoter . After transduction, activation of the MAPK/ERK signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
Myc Luciferase Reporter Lentivirus |
78628 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The Myc Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the Myc response element located upstream of the minimal TATA promoter and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, the Myc signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
p53 Luciferase Reporter Lentivirus |
78666 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The p53 Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by p53 response elements located upstream of the minimal TATA promoter (Figure 1) and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, p53-regulated gene expression in the target cells can be monitored by measuring the luciferase activity. |
HRE Luciferase Reporter Lentivirus |
78668 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The Hypoxia Response Element (HRE) Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by four copies of a hypoxia response elements (HRE) located upstream of the minimal TATA promoter (Figure 1) and an antibiotic selection gene (puromycin) for the selection of stable clones. After transduction, the induction of hypoxia in the target cells can be monitored by measuring the luciferase activity. |
ARE Luciferase Reporter Lentivirus |
79869 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Nrf2 antioxidant response pathway plays an important role in the cellular antioxidant defense. Nrf2, a basic leucine zipper transcription factor, induces the expression of antioxidant and phase II enzymes by binding to the ARE (antioxidant response element) region of the gene promoter. Under basal conditions, Nrf2 is retained in the cytosol by binding to the cytoskeletal protein Keap1. Upon exposure to oxidative stress or other ARE activators, Nrf2 is released from Keap1 and translocates to the nucleus, where it can bind to the ARE, leading to the expression of antioxidant and phase II enzymes that protect the cell from oxidative damage. The ARE Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by ARE located upstream of the minimal TATA promoter. After transduction, activation of the Nrf2 antioxidant response pathway in the target cells can be monitored by measuring the luciferase activity. |
TEAD Luciferase Reporter Lentivirus |
79833 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Hippo pathway regulates cell proliferation and cell death. It is activated by high cell density and cell stress to stop cell proliferation and induce apoptosis. The mammalian Hippo pathway comprises MST kinases and LATS kinases. When the Hippo pathway is activated, MST kinases phosphorylate LATS kinases, which phosphorylate transcriptional co-activators YAP and TAZ. Unphosphorylated YAP and TAZ remain in nucleus and interact with TEAD/TEF transcriptional factors to turn on cell cycle-promoting gene transcription. However, when phosphorylated, YAP and TAZ are recruited from the nucleus to the cytosol, so that the YAP and TAZ-dependent gene transcription is turned off. Dysfunction of the Hippo pathway is frequently detected in human cancer and its down-regulation correlates with the aggressive properties of cancer cells and poor prognosis. The TEAD Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the TEAD response elements located upstream of the minimal TATA promoter. After transduction, activation of the Hippo pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
STAT3 Luciferase Reporter Lentivirus |
79744 |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The STAT3 Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of STAT3-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the STAT3 signaling pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
STAT5 Luciferase Reporter Lentivirus |
79745 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The STAT5 Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of STAT5-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the STAT5 signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
NF-κB Luciferase Reporter Lentivirus |
79564 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The NF-κB Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by four copies of the NF-κB response element located upstream of the minimal TATA promoter. After transduction, activation of the NF-κB signaling pathway in the target cells can be monitored by measuring the luciferase activity. |